|
US4337760A
(en)
|
1978-10-13 |
1982-07-06 |
Adolf Schwimmer |
Method for the treatment of tumors with β-glucuronidase activity dependent pharmaceuticals
|
|
DE3360633D1
(en)
|
1982-02-12 |
1985-10-03 |
Unitika Ltd |
Anti-cancer device
|
|
US5800820A
(en)
|
1989-01-10 |
1998-09-01 |
Repligen Corporation |
Methods and compositions for treatment of angiogenic diseases
|
|
US5759837A
(en)
|
1989-01-17 |
1998-06-02 |
John Hopkins University |
Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IT1263831B
(it)
*
|
1993-01-29 |
1996-09-04 |
Paolo Chiesi |
Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
|
|
AU6676396A
(en)
|
1995-07-14 |
1997-02-18 |
Johns Hopkins University, The |
Tumor type ii hexokinase transcription regulatory regions
|
|
US5854067A
(en)
|
1996-01-19 |
1998-12-29 |
Board Of Regents, The University Of Texas System |
Hexokinase inhibitors
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6284786B1
(en)
|
1999-02-16 |
2001-09-04 |
The Center For The Improvement Of Human Functioning, Int'l., Inc. |
Treatment of cancer using lipoic acid in combination with ascorbic acid
|
|
US20020006915A1
(en)
|
2000-02-15 |
2002-01-17 |
Mack Strong Vivian E. |
Use of COX-2 inhibitors to treat sepsis, complications thereof, and EP receptor modulation
|
|
US6448030B1
(en)
|
2000-02-18 |
2002-09-10 |
University Of Nevada-Las Vegas |
Method for predicting the efficacy of anti-cancer drugs
|
|
AU2001245766A1
(en)
|
2000-03-14 |
2001-09-24 |
The Johns Hopkins University School Of Medicine |
Arrest of proliferation of highly glycolytic tumors
|
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
|
AU2002233916A1
(en)
|
2000-08-03 |
2002-04-29 |
Albert Einstein College Of Medicine |
Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
|
|
US7381713B2
(en)
|
2000-12-04 |
2008-06-03 |
Sioan-Kettering Institute For Cancer Research |
Treatment of cancer by reduction of intracellular energy and pyrimidines
|
|
US7547673B2
(en)
*
|
2001-09-13 |
2009-06-16 |
The Johns Hopkins University |
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
|
|
WO2004013307A2
(en)
|
2002-08-05 |
2004-02-12 |
Mirus Corporation |
Compounds for targeting hepatocytes
|
|
AU2004204778B2
(en)
|
2003-01-10 |
2008-05-22 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with 2-deoxyglucose
|
|
EP1610778A4
(en)
|
2003-01-17 |
2006-05-31 |
Threshold Pharmaceuticals Inc |
TREATMENT OF BENIGNER PROSTATE HYPERPLASIA
|
|
WO2006010073A1
(en)
|
2004-07-08 |
2006-01-26 |
Threshold Pharmaceuticals, Inc. |
Prevention of cancer
|
|
CA2575367A1
(en)
*
|
2004-07-28 |
2006-02-23 |
Board Of Regents, The University Of Texas System |
3-halo-2-oxopropionate salts and esters as novel anticancer agents
|
|
US7754693B2
(en)
|
2006-02-16 |
2010-07-13 |
Young Hee Ko |
Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
|
|
TWI478709B
(zh)
|
2008-02-19 |
2015-04-01 |
Earnest Medicine Co Ltd |
A useful oral or enteral composition for the recovery of bodily functions
|
|
AU2009259853A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Genentech, Inc. |
Triazolopyridine JAK inhibitor compounds and methods
|
|
WO2010021750A2
(en)
*
|
2008-08-21 |
2010-02-25 |
The Johns Hopkins University |
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
|
|
WO2012047339A2
(en)
*
|
2010-06-28 |
2012-04-12 |
The General Hospital Corporation |
Anti-cxcr4 as a sensitizer to cancer therapeutics
|
|
WO2014004651A1
(en)
*
|
2012-06-26 |
2014-01-03 |
The Johns Hopkins University |
Multifunctional tunable biomaterials for tissue engineering
|